Emerging Therapeutic Options for the Management of COPD

被引：10

作者：

Reid, Debra J. ^{[1
]}

Pham, Nga T. ^{[1
]}

机构：

[1] Northeastern Univ, Sch Pharm, Dept Pharm Practice, Boston, MA 02115 USA

来源：

CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE | 2013年 / 7卷

关键词：

chronic obstructive pulmonary disease; COPD therapy; long-acting muscarinic agent; phosphodiesterase-4; inhibitor; long-acting beta(2)-agonist;

D O I：

10.4137/CCRPM.S8140

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.

引用

页码：7 / 15

页数：9

共 38 条

[21] Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease [J].

Jones, Paul W. ;

Rennard, Stephen I. ;

Agusti, Alvar ;

Chanez, Pascal ;

Magnussen, Helgo ;

Fabbri, Leonardo ;

Donohue, James F. ;

Bateman, Eric D. ;

Gross, Nicholas J. ;

Lamarca, Rosa ;

Caracta, Cynthia ;

Gil, Esther Garcia .

RESPIRATORY RESEARCH, 2011, 12

[22] Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study [J].

Kerwin, Edward ;

Hebert, Jacques ;

Gallagher, Nicola ;

Martin, Carmen ;

Overend, Tim ;

Alagappan, Vijay K. T. ;

Lu, Yimeng ;

Banerji, Donald .

EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (05) :1106-1114

[23] Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I) [J].

Kerwin, Edward M. ;

D'Urzo, Anthony D. ;

Gelb, Arthur F. ;

Lakkis, Hassan ;

Garcia Gil, Esther ;

Caracta, Cynthia F. .

COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 9 (02) :90-101

[24] Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects - A double blind, randomized, placebo-controlled, cross-over clinical trial [J].

Kirsten, Anne ;

Watz, Henrik ;

Kretschmar, Gunther ;

Pedersen, Frauke ;

Bock, Daniel ;

Meyer-Sabellek, Wolfgang ;

Magnussen, Helgo .

PULMONARY PHARMACOLOGY & THERAPEUTICS, 2011, 24 (05) :555-558

[25] Safety and pharmacokinetics of multiple doses of aclidinium bromide administered twice daily in healthy volunteers [J].

Lasseter, K. ;

Dilzer, S. ;

Jansat, J. M. ;

Garcia Gil, E. ;

Caracta, C. F. ;

Ortiz, S. .

PULMONARY PHARMACOLOGY & THERAPEUTICS, 2012, 25 (02) :193-199

[26] Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison [J].

Mahler, Donald A. ;

D'Urzo, Anthony ;

Bateman, Eric D. ;

Ozkan, Serir A. ;

White, Tracy ;

Peckitt, Clare ;

Lassen, Cheryl ;

Kramer, Benjamin .

THORAX, 2012, 67 (09) :781-788

[27] New bronchodilators [J].

Mak, Garbo ;

Hanania, Nicola A. .

CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (03) :238-245

[28] Therapeutic potential for novel ultra long-acting β2-agonists in the management of COPD: biological and pharmacological aspects [J].

Malerba, Mario ;

Radaeli, Alessandro ;

Morjaria, Jaymin B. .

DRUG DISCOVERY TODAY, 2012, 17 (9-10) :496-504

[29] Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator - A Randomized trial [J].

Niewoehner, DE ;

Rice, K ;

Cote, C ;

Paulson, D ;

Cooper, JAD ;

Korducki, L ;

Cassino, C ;

Kesten, S .

ANNALS OF INTERNAL MEDICINE, 2005, 143 (05) :317-326

[30] Roflumilast -: an oral anti-inflammatory treatment for chronic obstructive pulmonary disease:: a randomised controlled trial [J].

Rabe, KF ;

Bateman, ED ;

O'Donnell, D ;

Witte, S ;

Bredenbröker, D ;

Bethke, TD .

LANCET, 2005, 366 (9485) :563-571

← 1 2 3 4 →